C07D 235/00
Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
C07D235/00 (Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings) appears on 4,169 US grants and 3,865 published applications in this corpus.
Search patents in C07D- Granted patents
- 4,169
- Published applications
- 3,865
- Assignees
- 1,683
- Inventors
- 12,439
- Latest grant
- 6 Oct 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 74 | 0 |
| 1977 | 45 | 0 |
| 1978 | 53 | 0 |
| 1979 | 49 | 0 |
| 1980 | 59 | 0 |
| 1981 | 58 | 0 |
| 1982 | 44 | 0 |
| 1983 | 28 | 0 |
| 1984 | 37 | 0 |
| 1985 | 51 | 0 |
| 1986 | 40 | 0 |
| 1987 | 30 | 0 |
| 1988 | 28 | 0 |
| 1989 | 39 | 0 |
| 1990 | 49 | 0 |
| 1991 | 52 | 0 |
| 1992 | 48 | 0 |
| 1993 | 54 | 0 |
| 1994 | 58 | 0 |
| 1995 | 62 | 0 |
| 1996 | 74 | 0 |
| 1997 | 86 | 0 |
| 1998 | 78 | 0 |
| 1999 | 83 | 0 |
| 2000 | 73 | 0 |
| 2001 | 95 | 20 |
| 2002 | 114 | 121 |
| 2003 | 87 | 155 |
| 2004 | 81 | 193 |
| 2005 | 76 | 155 |
| 2006 | 95 | 173 |
| 2007 | 115 | 174 |
| 2008 | 85 | 156 |
| 2009 | 94 | 187 |
| 2010 | 111 | 203 |
| 2011 | 134 | 172 |
| 2012 | 132 | 150 |
| 2013 | 135 | 141 |
| 2014 | 140 | 199 |
| 2015 | 168 | 151 |
| 2016 | 119 | 170 |
| 2017 | 124 | 169 |
| 2018 | 121 | 160 |
| 2019 | 141 | 151 |
| 2020 | 124 | 167 |
| 2021 | 123 | 145 |
| 2022 | 94 | 136 |
| 2023 | 76 | 144 |
| 2024 | 77 | 117 |
| 2025 | 97 | 86 |
| 2026 | 59 | 70 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Subgroups
Granted patents
Recent patents
- Methods of coupling a carbon containing moiety to an amine containing moiety6 Oct 2026US 12,753,155 B2Purdue Research Foundation
- Tautomeric ligand enables biomimetic C—H hydroxylation with molecular oxygen22 Sep 2026US 12,741,937 B2The Scripps Research Institute
- Nitrogen-containing condensed heterocyclic compound having an oxime group, agricultural or horticultural herbicide comprising the compound, and method for using the compound or the herbicide15 Sep 2026US 12,735,406 B2Nihon Nohyaku Co., Ltd.
- Compounds for the treatment of bacterial infections and potentiation of antibiotics8 Sep 2026US 12,728,105 B2Georgia State University Research Foundation, Inc.
- Direct aromatic carbon-oxygen and carbon-hydrogen bond functionalization via organic photoredox catalyst8 Sep 2026US 12,729,169 B2The University of North Carolina at Chapel Hill
- Bicyclic inhibitors of cbx chromodomains8 Oct 2026US 2026/0308130 A1Icahn School of Medicine at Mount Sinai
- Inhibitors of spinster homolog 2 (spns2) for use in therapy1 Oct 2026US 2026/0297044 A1University of Virginia Patent Foundation
- Aromatic substituent-containing (hetero) aryl-imidazole compound, and preparation method therefor and use thereof1 Oct 2026US 2026/0297065 A1Open Source Therapeutics
- Compounds for restoring susceptibility to beta-lactam antibiotics24 Sep 2026US 2026/0284011 A1University of Notre Dame du Lac
- Compounds, compositions and methods thereof24 Sep 2026US 2026/0285869 A1Hepaitech (Beijing) Biopharma Technology Co., Ltd.
Most cited
By later US patents
- Method for deuteration of a heterocyclic ring304US 7,517,990 B2Wako Pure Chemical Industries, Ltd. · 2009
- Heterocyclic compounds useful as inhibitors of tyrosine kinases202US 6,506,769 B2Boehringer Ingelheim Pharmaceuticals, Inc. · 2003
- Heterocyclic compounds useful as inhibitors of tyrosine kinases190US 6,770,639 B2Boehringer Ingelheim Pharmaceuticals, Inc. · 2004
- Angiotensin II receptor blocking benzimidazoles184US 4,880,804 AE. I. Du Pont de Nemours and Company · 1989
- Benzo (b) thiophene carboxylate derivatives and pharmaceutical compositions182US 4,740,519 ACentre International de Recherches Dermatologiques (C.I.R.D.) · 1988